Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma

Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma

The development of immune checkpoint inhibitors (ICI) has dramatically changed the landscape of therapies for metastatic renal cell carcinoma. However, many patients do not benefit from such therapy and prognostic or predictive validated biomarker validated for ICI are still needed to better select...

Full description

Bibliographic Details
Main Authors:	Emilien Billon, Brice Chanez, Philippe Rochigneux, Laurence Albiges, Cécile Vicier, Géraldine Pignot, Jochen Walz, Anne-Sophie Chretien, Gwenaelle Gravis, Daniel Olive
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Immunology
Subjects:	renal cell carcinoma butyrophilin nivolumab immunotherapy γδ T cells
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.670827/full

Similar Items

New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity
by: Juan-Luis Blazquez, et al.
Published: (2018-07-01)

Vitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma
by: Emilien Billon, et al.
Published: (2019-10-01)

Editorial: γδ T Cells in Cancer
by: Seth B. Coffelt, et al.
Published: (2020-11-01)

Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma
by: Benjamin Bian, et al.
Published: (2019-04-01)

An Update on the Molecular Basis of Phosphoantigen Recognition by Vγ9Vδ2 T Cells
by: Thomas Herrmann, et al.
Published: (2020-06-01)

Bibliometrics Analysis of Butyrophilins as Immune Regulators [1992–2019] and Implications for Cancer Prognosis
by: Yixi Wang, et al.
Published: (2020-06-01)

Medical Treatment of Lung Cancer: Can Immune Cells Predict the Response? A Systematic Review
by: Philippe Rochigneux, et al.
Published: (2020-06-01)

Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells
by: Lola Boutin, et al.
Published: (2018-04-01)

Allelic diversity of butyrophilin (BTN1A1) gene in Indian bovines
by: Manoj Kumar, et al.
Published: (2018-02-01)

Regulation of Human γδ T Cells by BTN3A1 Protein Stability and ATP-Binding Cassette Transporters
by: David A. Rhodes, et al.
Published: (2018-04-01)

BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC)
by: Audrey Benyamine, et al.
Published: (2018-01-01)

High Abundance of Intratumoral γδ T Cells Favors a Better Prognosis in Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis
by: Huanzi Lu, et al.
Published: (2020-09-01)

Hyperprogressive Disease in Anorectal Melanoma Treated by PD-1 Inhibitors
by: Marjorie Faure, et al.
Published: (2018-04-01)

Radio(chemo)therapy in elderly patients with oesophageal cancer : a feasible treatment with an outcome consistent with younger patients.
by: Philippe eRochigneux, et al.
Published: (2014-05-01)

BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells
by: Carla E. Cano, et al.
Published: (2021-07-01)

Adoptive Cell Therapy in Hepatocellular Carcinoma: Biological Rationale and First Results in Early Phase Clinical Trials
by: Philippe Rochigneux, et al.
Published: (2021-01-01)

Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity
by: Maria Raffaella Zocchi, et al.
Published: (2017-03-01)

Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2<sup>+</sup> γδ T Cell Alterations with Lymph Node Invasion
by: Stéphane Fattori, et al.
Published: (2021-01-01)

Tissue Adaptations of Memory and Tissue-Resident Gamma Delta T Cells
by: Camille Khairallah, et al.
Published: (2018-11-01)

Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival?
by: Daniele Fanale, et al.
Published: (2021-04-01)

Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-Oncology
by: Sandrine Rousset-Rouviere, et al.
Published: (2021-06-01)

Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review
by: Philippe Rochigneux, et al.
Published: (2018-11-01)

Cancer immunotherapy using γδT cells: dealing with diversity
by: Wouter eScheper, et al.
Published: (2014-11-01)

Role of γδ T cells in mucosal intranet
by: Masafumi Yamamoto, et al.
Published: (1999-01-01)

Expanded human blood-derived γδT cells display potent antigen-presentation functions
by: Mohd Wajid Ali Khan, et al.
Published: (2014-07-01)

The Vγ9Vδ2 T cell antigen receptor and butyrophilin 3 A1 (BTN3A1): Models of interaction, the possibility of co-evolution, and the case of dendritic epidermal T cells
by: Mohindar Murugesh eKarunakaran, et al.
Published: (2014-12-01)

A highly focused antigen receptor repertoire characterizes γδ T cells that are poised to make IL-17 rapidly in naive animals
by: Yu-Ling eWei, et al.
Published: (2015-03-01)

Ciblage de BTN3A en immunothérapie anti-tumorale basée sur les lymphocytes T Vγ9Vδ2 : Application aux Leucémies aiguës Myéloïdes et au cancer du pancréas
by: Benyamine, Audrey
Published: (2015)

Potent Bidirectional Cross-Talk Between Plasmacytoid Dendritic Cells and γδT Cells Through BTN3A, Type I/II IFNs and Immune Checkpoints
by: Pauline Girard, et al.
Published: (2020-05-01)

ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells
by: Chiara Riganti, et al.
Published: (2018-06-01)

γδT Cells Suppress Liver Fibrosis via Strong Cytolysis and Enhanced NK Cell-Mediated Cytotoxicity Against Hepatic Stellate Cells
by: Meifang Liu, et al.
Published: (2019-03-01)

Human γδ TCR Repertoires in Health and Disease
by: Alina Suzann Fichtner, et al.
Published: (2020-03-01)

Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions
by: Lorena Incorvaia, et al.
Published: (2020-01-01)

Gamma-delta (γδ) T-cell lymphoma – another case unclassifiable by World Health Organization classification: a case report
by: Hemant Sindhu, et al.
Published: (2017-06-01)

PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences are Emerging—A Literature Review
by: Gabrielle Planes-Laine, et al.
Published: (2019-07-01)

Revisiting the Interaction of γδ T-Cells and B-Cells
by: Francesca Rampoldi, et al.
Published: (2020-03-01)

Imbalance of γδT17/γδTreg cells in the pathogenesis of allergic asthma induced by ovalbumin
by: Xia Yang, et al.
Published: (2018-07-01)

Sonic Hedgehog Is a Determinant of γδ T-Cell Differentiation in the Thymus
by: Konstantinos Mengrelis, et al.
Published: (2019-07-01)

Stenotrophomonas maltophilia with histopathological features mimicking cutaneous gamma/delta T-cell lymphoma
by: Natalie Kash, et al.
Published: (2015-01-01)

The Jekyll and Hyde story of IL17 producing γδT (Tγδ17) cells
by: Rushikesh Sudam Patil, et al.
Published: (2015-02-01)